GDF-15 and hepcidin as a therapeutic target for anemia in chronic kidney disease
Abstract Background Anaemia is a common presenting feature among patients with chronic kidney disease (CKD) and associated with poor clinical outcomes. We evaluated the diagnostic validity of growth differentiation factor-15 (GDF-15) and hepcidin as it is not clear if they are useful as a biomarkers...
Saved in:
Main Authors: | Naglaa Makram Farag (Author), Mahmoud Mousa (Author), Eman Elsayed (Author), Ahlam Ismeil (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2023-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Understanding and exploiting hepcidin as an indicator of anemia due to chronic kidney disease
by: Derek S. Larson, et al.
Published: (2013) -
Iron, anemia and hepcidin in malaria
by: Natasha eSpottiswoode, et al.
Published: (2014) -
Hepcidin Therapeutics
by: Angeliki Katsarou, et al.
Published: (2018) -
Exercise increases circulating GDF15 in humans
by: Maximilian Kleinert, et al.
Published: (2018) -
The relationship between anemia, serum hepcidin levels, and chronic hepatitis C in chronic hemodialysis patients
by: Maher A Al-Amir, et al.
Published: (2017)